The pharmaceutical composition, viable anaerobic bacteria comprising, which inhibit the sulfate reduction sulfate-reducing bacteria

摘要

, Pharmaceutical agents are described, the anaerobic, viable bacterial, which inhibit the sulfate reduction sulfate-reducing bacteria. Preferably, the bacteria contained in the medicament according to the invention by bifidobacteria. The medicament according to the invention is preferably for the treatment of the "inflammatory bowel disease" (ibd) or states caused thereby used. Furthermore, a drug is described, the the above described bacteria in combination with prebiotic additives and contains, for example, for the strengthening of gram - positive bacteria of the intestinal microflora can be used.